当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析

鲁抗医药

(600789)

  

流通市值:88.43亿  总市值:88.43亿
流通股本:8.99亿   总股本:8.99亿

鲁抗医药(600789)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.11亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益409134.92万元,未分配利润116205.02万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产888736.30万元,负债479601.38万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,153,993,569.881,673,699,598.016,233,090,168.384,666,958,713.84
营业总成本2,972,941,889.511,603,575,969.645,966,978,980.464,545,910,874.37
其他经营收益
营业利润146,923,738.3285,861,702.38436,189,761.86372,540,378.91
利润总额142,932,282.7286,029,587.01433,901,412.51372,328,111.64
净利润110,648,217.6582,348,970.57408,347,521.83356,919,215.41
每股收益
其他综合收益-1,387,189.78-1,306,169.17-7,452,241.92-2,431,348.64
综合收益总额109,261,027.8781,042,801.4400,895,279.91354,487,866.77
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,916,634,147.394,169,336,837.374,130,301,803.624,203,339,916.12
非流动资产:
非流动资产合计4,970,728,841.834,966,570,142.344,967,683,072.84,946,699,079.03
资产总计8,887,362,989.229,135,906,979.719,097,984,876.429,150,038,995.15
流动负债:
流动负债合计3,145,711,765.353,259,579,625.773,060,932,068.623,490,459,778.07
非流动负债:
非流动负债合计1,650,302,009.361,733,613,899.561,975,482,433.061,626,595,588.43
负债合计4,796,013,774.714,993,193,525.335,036,414,501.685,117,055,366.5
所有者权益(或股东权益):
归属于母公司股东权益合计3,944,150,813.153,995,576,973.313,918,185,214.353,893,469,477.55
股东权益合计4,091,349,214.514,142,713,454.384,061,570,374.744,032,983,628.65
负债和股东权益合计8,887,362,989.229,135,906,979.719,097,984,876.429,150,038,995.15
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,631,087,931.491,280,615,436.195,519,103,108.23,786,030,177.32
经营活动现金流出小计2,318,750,652.911,253,744,242.535,116,285,051.073,381,315,919.52
经营活动产生的现金流量净额312,337,278.5826,871,193.66402,818,057.13404,714,257.8
投资活动产生的现金流量:
投资活动现金流入小计29,084,163.258,017.420,312,302.2420,153,581.09
投资活动现金流出小计134,413,489.7968,060,294.89279,181,894.96196,879,757.19
投资活动产生的现金流量净额-105,329,326.59-68,002,277.49-258,869,592.72-176,726,176.1
筹资活动产生的现金流量:
筹资活动现金流入小计861,378,558.24601,000,0001,858,560,025.4921,355,157.81
筹资活动现金流出小计984,161,885.46605,003,435.492,047,659,990.381,109,657,070.22
筹资活动产生的现金流量净额-122,783,327.22-4,003,435.49-189,099,964.98-188,301,912.41
汇率变动对现金及现金等价物的影响5,177,073.161,019,984.4910,806,795.175,692,870.33
现金及现金等价物净增加额89,401,697.93-44,114,534.83-34,344,705.445,379,039.62
期末现金及现金等价物余额585,102,889.9452,094,745.14495,701,191.97575,424,936.99
补充资料:
现金及现金等价物的净增加额89,401,697.93--34,344,705.4-
TOP↑